{"id":"intravenous-milrinone","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Tachycardia"},{"rate":"5-10%","effect":"Arrhythmias"},{"rate":"5-10%","effect":"Nausea and vomiting"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL1200977","moleculeType":"Small molecule","molecularWeight":"301.30"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting phosphodiesterase 3, milrinone increases the levels of cyclic AMP in cardiac muscle cells, leading to increased contractility and vasodilation. This results in improved cardiac output and reduced pulmonary artery pressure.","oneSentence":"Milrinone is a phosphodiesterase 3 inhibitor that increases cardiac contractility and vasodilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:16:48.244Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute heart failure"},{"name":"Cardiogenic shock"}]},"trialDetails":[{"nctId":"NCT07144267","phase":"NA","title":"Comparison of Milrinone and Epinephrine on TAPSE","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-03-01","conditions":"Cardiac Anaesthesia, Cardiopulmonary Bypass","enrollment":102},{"nctId":"NCT02951130","phase":"PHASE2","title":"Milrinone in Congenital Diaphragmatic Hernia","status":"COMPLETED","sponsor":"NICHD Neonatal Research Network","startDate":"2017-10-24","conditions":"Congenital Diaphragmatic Hernia, Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure","enrollment":66},{"nctId":"NCT04718350","phase":"NA","title":"Treatment of Pulmonary Hypertension in High-risk Cardiac Surgery Patients Using Inhalational and Intravenous Agents","status":"COMPLETED","sponsor":"Aretaieion University Hospital","startDate":"2021-01-27","conditions":"Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality","enrollment":40},{"nctId":"NCT06679855","phase":"PHASE3","title":"Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial","status":"RECRUITING","sponsor":"NICHD Neonatal Research Network","startDate":"2025-06-13","conditions":"Post-ligation Cardiac Syndrome","enrollment":316},{"nctId":"NCT03180450","phase":"PHASE1, PHASE2","title":"The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF)","status":"SUSPENDED","sponsor":"Sclnow Biotechnology Co., Ltd.","startDate":"2025-12-31","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT04484675","phase":"PHASE4","title":"Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2023-05-20","conditions":"Pulmonary Hypertension Due to Left Heart Disease","enrollment":38},{"nctId":"NCT05267886","phase":"PHASE4","title":"CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2022-03-05","conditions":"Shock, Cardiogenic","enrollment":346},{"nctId":"NCT05838846","phase":"PHASE2, PHASE3","title":"Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2023-04-01","conditions":"Mitral Valve Replacement, Pulmonary Hypertension, Inhaled Milrinone","enrollment":60},{"nctId":"NCT02098629","phase":"PHASE2","title":"Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial Infarction","status":"COMPLETED","sponsor":"Shantou University Medical College","startDate":"2015-05","conditions":"Myocardial Reperfusion Injury","enrollment":25},{"nctId":"NCT04282629","phase":"PHASE2","title":"Cerebral Hemodynamic Optimization by Milrinone to Prevent Delayed Cerebral Ischemia","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2021-07-25","conditions":"Aneurysmal Subarachnoid Hemorrhage","enrollment":234},{"nctId":"NCT06562036","phase":"NA","title":"Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2023-12-01","conditions":"Persistent Pulmonary Hypertension of the Newborn","enrollment":42},{"nctId":"NCT06077721","phase":"","title":"Milrinone on Right Ventricular Strain in Cardiac Surgery","status":"UNKNOWN","sponsor":"Konkuk University Medical Center","startDate":"2023-11-03","conditions":"Ischemic Heart Disease, Valvular Heart Disease","enrollment":41},{"nctId":"NCT04665583","phase":"","title":"Prehab Prior to Undergoing Tricuspid Intervention","status":"TERMINATED","sponsor":"Baylor Research Institute","startDate":"2020-10-25","conditions":"Tricuspid Valve Disease, Tricuspid Regurgitation","enrollment":9},{"nctId":"NCT03160846","phase":"","title":"The Inotrope Evaluation and Research Patient Registry","status":"COMPLETED","sponsor":"Coram Clinical Trials","startDate":"2014-08-25","conditions":"Heart Failure","enrollment":129},{"nctId":"NCT05131867","phase":"PHASE2","title":"Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2021-11-24","conditions":"Oral Nimodipine, Milrinone, Vascular Spasm After Traumatic Subarachnoidhaemorrhage","enrollment":30},{"nctId":"NCT03517670","phase":"","title":"Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2020-08-31","conditions":"Cerebral Vasospasm, Subarachnoid Hemorrhage","enrollment":60},{"nctId":"NCT04391478","phase":"PHASE1","title":"Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rania Ali El-Farrash","startDate":"2015-01","conditions":"Persistent Pulmonary Hypertension","enrollment":40},{"nctId":"NCT02726620","phase":"NA","title":"Decision Support for Intraoperative Low Blood Pressure","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-01-05","conditions":"Hypotension","enrollment":22435},{"nctId":"NCT03823781","phase":"PHASE3","title":"Prophylactic Use of Milrinone After Congenital Heart Surgery in Infants","status":"UNKNOWN","sponsor":"Shanghai Children's Medical Center","startDate":"2019-02","conditions":"Low Cardiac Output Syndrome, Cardiac Surgical Procedures, Infant","enrollment":520},{"nctId":"NCT02644057","phase":"PHASE2","title":"Dobutamaine Versus Milrinone in Cardiorenal Syndrome","status":"WITHDRAWN","sponsor":"Maimonides Medical Center","startDate":"2016-03","conditions":"Cardiorenal Syndrome","enrollment":""},{"nctId":"NCT00543309","phase":"PHASE2","title":"Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery","status":"TERMINATED","sponsor":"John M Costello","startDate":"2007-10","conditions":"Heart Defects, Congenital","enrollment":106},{"nctId":"NCT01088997","phase":"NA","title":"Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn","status":"TERMINATED","sponsor":"Children's Hospital of Philadelphia","startDate":"2010-06","conditions":"Persistent Fetal Circulation Syndrome","enrollment":12},{"nctId":"NCT02595541","phase":"PHASE1, PHASE2","title":"Oral Sildenafil and Intravenous Milrinone on Postoperative Pulmonary Hypertension","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-06","conditions":"Pulmonary Hypertension","enrollment":30},{"nctId":"NCT01849094","phase":"PHASE1, PHASE2","title":"Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone","status":"COMPLETED","sponsor":"The Alfred","startDate":"2013-05","conditions":"Healthy, Heart Failure","enrollment":9},{"nctId":"NCT01301313","phase":"PHASE2","title":"Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children","status":"TERMINATED","sponsor":"Jose Luis Vazquez Martinez","startDate":"2011-02","conditions":"Acute Heart Failure","enrollment":116},{"nctId":"NCT01621971","phase":"PHASE3","title":"Effect of Brief Nebulization of Milrinone on Pulmonary Arterial Pressure Before Cardiopulmonary Bypass on Mitral Valve Surgery Patients","status":"COMPLETED","sponsor":"Konkuk University Medical Center","startDate":"2003-01","conditions":"Pulmonary Hypertension, Mitral Regurgitation","enrollment":20},{"nctId":"NCT01576094","phase":"PHASE1, PHASE2","title":"Two Inodilators Postsurgery in Neonates","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz","startDate":"2009-11","conditions":"Low Cardiac Output Syndrome","enrollment":20},{"nctId":"NCT00695929","phase":"NA","title":"Levosimendan in Congenital Cardiac Surgery","status":"COMPLETED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2008-07","conditions":"Congenital Cardiovascular Defects, Low Cardiac Output Syndrome","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":191,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Primacor, Sanofi-Synthelabo Canada Inc., Markham, ON, Canada"],"phase":"phase_3","status":"active","brandName":"intravenous milrinone","genericName":"intravenous milrinone","companyName":"Konkuk University Medical Center","companyId":"konkuk-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Milrinone is a phosphodiesterase 3 inhibitor that increases cardiac contractility and vasodilation. Used for Acute heart failure, Cardiogenic shock.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}